RANDAL J KIRK, a director at $PGEN, sold 1,403,360 shares of the company on 09-18-2025 for an estimated $5,416,969. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.4% of their shares of this class of stock. Following this trade, they now own 12,117,429 shares of this class of $PGEN stock.
$PGEN Insider Trading Activity
$PGEN insiders have traded $PGEN stock on the open market 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PGEN stock by insiders over the last 6 months:
- RANDAL J KIRK has made 0 purchases and 2 sales selling 5,000,252 shares for an estimated $18,653,532.
- NANCY H AGEE has made 3 purchases buying 41,005 shares for an estimated $167,642 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PGEN Hedge Fund Activity
We have seen 70 institutional investors add shares of $PGEN stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARKMAN HEALTHCARE PARTNERS LLC removed 1,648,520 shares (-51.7%) from their portfolio in Q2 2025, for an estimated $2,340,898
- SCHONFELD STRATEGIC ADVISORS LLC removed 1,355,786 shares (-48.5%) from their portfolio in Q2 2025, for an estimated $1,925,216
- PATIENT CAPITAL MANAGEMENT, LLC removed 1,103,560 shares (-6.4%) from their portfolio in Q2 2025, for an estimated $1,567,055
- MORGAN STANLEY added 1,007,864 shares (+97.6%) to their portfolio in Q2 2025, for an estimated $1,431,166
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 975,244 shares (+593.0%) to their portfolio in Q2 2025, for an estimated $1,384,846
- BANK OF AMERICA CORP /DE/ added 599,914 shares (+258.2%) to their portfolio in Q2 2025, for an estimated $851,877
- RENAISSANCE TECHNOLOGIES LLC removed 505,400 shares (-63.7%) from their portfolio in Q2 2025, for an estimated $717,668
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PGEN Analyst Ratings
Wall Street analysts have issued reports on $PGEN in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 08/19/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/19/2025
- Cantor Fitzgerald issued a "Overweight" rating on 05/15/2025
To track analyst ratings and price targets for $PGEN, check out Quiver Quantitative's $PGEN forecast page.
$PGEN Price Targets
Multiple analysts have issued price targets for $PGEN recently. We have seen 3 analysts offer price targets for $PGEN in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $8.5 on 08/19/2025
- Jason N. Butler from JMP Securities set a target price of $8.0 on 08/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
